Compugen | CGEN - Fremdkapital





Fremdkapital Veränderung Datum
aTyr Pharma USD 12.51M 12.11M 2025-12
Bio Path USD 0 0 2025-03
Brainstorm Cell Therapeutics USD 0 0 2025-03
Cara Therapeutics USD 0 0 2025-03
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
Immunic USD 0 0 2024-06
Infinity Pharmaceuticals USD 0 0 2022-06
Minerva Neurosciences USD 0 86.58M 2024-09
RedHill Biopharma USD 190K 0 2024-06
TherapeuticsMD USD 0 0 2022-03